Clinical Trial Update: Survey Study for Velaglucerase Alfa (VPRIV) in Japan

View source ↗

Summary

A survey study evaluating velaglucerase alfa (VPRIV) in Gaucher disease patients in Japan has completed, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• VPRIV (velaglucerase alfa) (velaglucerase alfa)

Snippet

Sponsor: Takeda | Conditions: Gaucher Disease | Status: COMPLETED | Results posted: 2025-01-10